Glooko to Expand EMEA CGM Connectivity

Glooko Inc.’s diabetes management platform will integrate with the Roche Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution across select European countries, subject to local availability,* the company announced today.

The integration will enable patients using the Accu-Chek SmartGuide CGM to bring their CGM data into Glooko, alongside data from other connected diabetes and health monitoring devices. This can reduce the administrative burden for healthcare teams, enabling them to view key insights in one place and support effective collaboration between patient visits.

Accu-Chek SmartGuide is Roche’s artificial intelligence (AI)-enabled CGM solution designed to provide real-time glucose readings and predictive insights across multiple timeframes. The system includes the Accu-Chek SmartGuide sensor and an application to view and analyze CGM glucose values and predictions. With an all-in-one applicator and 14-day wear time, Accu-Chek SmartGuide is designed for people living with diabetes, ages 18 and older. Built-in predictive capabilities help users anticipate glucose trends, including forecasts up to two hours ahead and overnight risk insights, supporting proactive diabetes management.

“Diabetes data is only powerful when it’s accessible, connected, and easy to act on,” Glooko CEO Mike Alvarez stated. “By integrating Roche’s Accu-Chek SmartGuide CGM into the Glooko platform, we’re expanding choice for people with diabetes and clinicians. Now, they can bring Accu-Chek SmartGuide CGM data together with the rest of the patient’s health and medication therapy context, in a single experience designed to support better, more informed decisions.”

Glooko is reportedly the first diabetes data management platform outside of Roche’s ecosystem that will integrate with the Accu-Chek SmartGuide CGM. The integration is designed to help address a common challenge in diabetes care: data that lives in separate device-specific apps and portals, making it harder for patients and clinicians to see the full picture.

The Accu-Chek SmartGuide CGM integration will be available on the Glooko platform in key markets across Europe in the next several weeks, subject to country availability and local regulatory and market requirements.

Glooko Inc. is a global digital health company helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. Glooko is positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings.

* Functionality will be rolled out on a market-by-market basis in Austria, Belgium, the Czech Republic, Denmark, Finland, France, Germany, Italy, the Netherlands, Norway, Sweden, and the United Kingdom.